Role of CYP2C8 and CYP2J2 genotype in renal-induced toxicity of calcineurin inhibitors

被引：0
|
作者：
Smith, Helen E.
Thummel, Kenneth E.
Fallon, Michael J.
Jones, J. P.
Totah, Rheem A.
Farin, Fred M.
Janssen, Patricia
Hebert, Mary F.
机构：
[1] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[2] Univ Washington, Environm Hlth, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
321
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [31] Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms
    Yasar, U
    Lundgren, S
    Eliasson, E
    Bennet, A
    Wiman, B
    de Faire, U
    Rane, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (01) : 25 - 28
  • [32] Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications
    Sisignano, Marco
    Steinhilber, Dieter
    Parnham, Michael J.
    Geisslinger, Gerd
    DRUG DISCOVERY TODAY, 2020, 25 (09) : 1744 - 1753
  • [33] Global variation in CYP2C8–CYP2C9 functional haplotypes
    William C Speed
    Soonmo Peter Kang
    David P Tuck
    Lyndsay N Harris
    Kenneth K Kidd
    The Pharmacogenomics Journal, 2009, 9 : 283 - 290
  • [34] CYP2C8 polymorphism among the Portuguese
    Cavaco, I
    Piedade, R
    Gil, JP
    Ribeiro, V
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 168 - 170
  • [35] CYP2C8 and antimalaria drug efficacy
    Gill, J. P.
    Berglund, E. Gil
    PHARMACOGENOMICS, 2007, 8 (02) : 187 - 198
  • [36] Effect of itraconazole and rifampin on the pharmacokinetics and pharmacodynamics of ebastine in relation to CYP2J2*8 genotype.
    Shon, J
    Yeo, C
    Liu, K
    Lee, S
    Cha, I
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P9 - P9
  • [37] Roles of the epoxygenase CYP2J2 in the endothelium
    Askari, Ara
    Thomson, Scott J.
    Edin, Matthew L.
    Zeldin, Darryl C.
    Bishop-Bailey, David
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 107 : 56 - 63
  • [38] Human Liver Expression of CYP2C8: Gender, Age, and Genotype Effects
    Naraharisetti, Suresh Babu
    Lin, Yvonne S.
    Rieder, Mark J.
    Marciante, Kristin D.
    Psaty, Bruce M.
    Thummel, Kenneth E.
    Totah, Rheem A.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (06) : 889 - 893
  • [39] Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug-drug interactions
    Gao, Yiwen
    Liu, Duan
    Wang, Huijuan
    Zhu, Juanli
    Chen, Chao
    XENOBIOTICA, 2010, 40 (07) : 467 - 475
  • [40] Autoinhibition of CYP3A4 Leads to Important Role of CYP2C8 in Imatinib Metabolism: Variability in CYP2C8 Activity May Alter Plasma Concentrations and Response
    Filppula, Anne M.
    Neuvonen, Mikko
    Laitila, Jouko
    Neuvonen, Pertti J.
    Backman, Janne T.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 50 - 59
12345